Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Abstract Background There has been a significant improvement in survival of advanced malignancies with the advent of checkpoint inhibitors.These newer treatment modalities come with a wide spectrum of unique side effects, termed immune related adverse events (irAE), ranging from mild skin rash to severe colitis.Included in that spectrum is the rare